Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis

Open access
Henry, Brandon Michael, de Oliveira, Maria Helena Santos, Benoit, Stefanie, Plebani, Mario, Lippi, Giuseppe · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)

Abstract

Background As coronavirus disease 2019 (COVID-19) pandemic rages on, there is urgent need for identification of clinical and laboratory predictors for progression towards severe and fatal forms of this illness. In this study we aimed to evaluate the discriminative ability of hematologic, biochemical and immunologic biomarkers in patients with and without the severe or fatal forms of COVID-19. Methods An electronic search in Medline (PubMed interface), Scopus, Web of Science and China National Knowledge Infrastructure (CNKI) was performed, to identify studies reporting on laboratory abnormalities in patients with COVID-19. Studies were divided into two separate cohorts for analysis: severity (severe vs. non-severe and mortality, i.e. non-survivors vs. survivors). Data was pooled into a meta-analysis to estimate weighted mean difference (WMD) with 95% confidence interval (95% CI) for each laboratory parameter. Results A total number of 21 studies was included, totaling 3377 patients and 33 laboratory parameters. While 18 studies (n = 2984) compared laboratory findings between patients with severe and non-severe COVID-19, the other three (n = 393) compared survivors and non-survivors of the disease and were thus analyzed separately. Patients with severe and fatal disease had significantly increased white blood cell (WBC) count, and decreased lymphocyte and platelet counts compared to non-severe disease and survivors. Biomarkers of inflammation, cardiac and muscle injury, liver and kidney function and coagulation measures were also significantly elevated in patients with both severe and fatal COVID-19. Interleukins 6 (IL-6) and 10 (IL-10) and serum ferritin were strong discriminators for severe disease. Conclusions Several biomarkers which may potentially aid in risk stratification models for predicting severe and fatal COVID-19 were identified. In hospitalized patients with respiratory distress, we recommend clinicians closely monitor WBC count, lymphocyte count, platelet count, IL-6 and serum ferritin as markers for potential progression to critical illness.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/cclm-2020-0369

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 2

  1. Liu M, He P, Liu M, Wang X, Li F, Chen S, et al. [Analysis of clinical characteristics of 30 cases of new coronavirus pneumonia in medical staff]. Chin J Tuberculosis Respir Dis 2020;43:209–14.
  2. Tianxin X, Liu J, Xu F, Cheng N, Liu Y, Qian K. [Analysis of clinical features of 49 patients with new type of coronavirus pneumonia in Jiangxi]. Chin J Respir Crit Care 2020. doi:10.7507/1671-6205.202002070. · doi:10.7507/1671-6205.202002070

Cited by

See all 1,964

Metadata

Authors
Henry, B. M., de Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G.
Affiliations
  • Cincinnati Children's Hospital Medical Center (US)
  • Department of Statistics , Federal University of Parana , Curitiba , Brazil
  • University of Padua (IT)
  • University of Verona (IT)
Corresponding author
Lippi, Giuseppe
Venue
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2020-04-10
Volume
58
Issue
7
Pages
1021-1028
ISSN
  • 1434-6621 (ISSN-L)
  • 1437-4331
OpenAlex
W3016127406
Cited by
1,964
References
29
Citations by year
2026: 43 · 2025: 72 · 2024: 145 · 2023: 240 · 2022: 445 · 2021: 599 · 2020: 419
FWCI
20.13
Type
journal article
Language
en
Open access
Locations
  • Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
Keywords
COVID-19 pandemic, SARS-CoV-2, laboratory biomarkers, disease severity, mortality, white blood cell count, lymphocyte count, platelet count, interleukin-6, IL-10, serum ferritin, inflammatory markers, coagulation, liver and kidney function, risk stratification, prognostic factors
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Humans, Inflammation, Leukocyte Count, Platelet Count, Pneumonia, Viral, Risk Factors, Severity of Illness Index, Biomarkers, Interleukin-6, Interleukin-10, Coronavirus, Coronavirus Infections, Lymphocyte Count, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. https://app.cochat.ai/papers/10.1515/cclm-2020-0369
The paper
Henry, B. M., de Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020). Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2020-0369

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.